BioMarin vs Spark Therapeutics
BioMarin vs Spark Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioMarin is on 36/100 and Spark Therapeutics on 58/100.
Where each one leads
BioMarin
Leads on none of the measures we hold for both companies.
Spark Therapeutics
- our overall score: 58/100 against 36/100
- domain rating: 80/100 against 72/100
At a glance
| Measure | BioMarin | Spark Therapeutics |
|---|---|---|
| What it is | A global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Rare Diseases, Genetic Disorders, Enzyme Replacement Therapies | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Services |
| Founded | 1997 | 2013 |
| Headquarters | San Rafael, United States | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioMarin | Spark Therapeutics |
|---|---|---|
| Employees | 3,163 | Not published |
| Total funding | Not published | $82.8M |
| Latest round | Not published | Series B |
| LinkedIn followers | 225,828 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioMarin | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 58/100 |
| Traction | 20/100 | 40/100 |
| Team | 70/100 | 90/100 |
| Search visibility | 23/100 | 13/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 72/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioMarin | Spark Therapeutics |
|---|---|---|
| Hosting | Azure | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Tag Manager |
What users say
| Measure | BioMarin | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
BioMarin vs Spark Therapeutics: common questions
Which is better, BioMarin or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do BioMarin and Spark Therapeutics compare on the numbers?
Spark Therapeutics leads on our overall score (58/100 against 36/100), domain rating (80/100 against 72/100).
What do real users say about BioMarin and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full BioMarin review and pricing or the Spark Therapeutics review and pricing. You can also browse other BioMarin alternatives we track.